To assess the effect of ERB-041 after multiple oral doses on cardiac repolarization as assessed by the QTc interval.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
64
Unnamed facility
Miami, Florida, United States
To assess the effect of ERB-041 after multiple oral doses on cardiac repolarization as assessed by the QTc interval
To characterize pharmacokinetic and pharmacodynamic relationships as it relates to QTc.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.